| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.4 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |